Pancreatic Cancer Research

ResearcherThe University of Texas at AustinNo recent work listed

Stephen D Hursting

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3605-2833; OpenAlex author ID A5036400845; NIH RePORTER profile ID 2551937. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 5)
Trials
0
Grants
1
Labs led
2
Collaborators
22
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper, 1 grant · 2022: 1 paper

Papers 6

  1. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. Co-author DOI 10.1158/0008-5472.can-21-1443↗
  2. β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers13246359↗
  3. Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms. Last author DOI 10.2337/db14-1132↗
  4. Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice. Last author DOI 10.1186/2049-3002-2-6↗
  5. Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I. Last author DOI 10.1158/1940-6207.capr-13-0185↗
  6. Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer. Last author DOI 10.1158/1940-6207.capr-11-0023↗

Grants 1

  1. Breaking the Obesity-Cancer Link: New Targets and Strategies R35CA197627↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Delisha A Stewart · 1 shared grant, 2021 · strength 0.44
  2. John Edgar French · 1 shared grant, 2021 · strength 0.44
  3. Laura M. Lashinger · 5 shared papers, 2011–2021 · strength 0.32
  4. Michael F. Coleman · 2 shared papers, 2021–2022 · strength 0.26
  5. Kristyn A. Liu · 2 shared papers, 2014–2021 · strength 0.19
  6. Zhengrong Cui · 1 shared paper, 2021 · strength 0.13
  7. Xiaohu Tang · 1 shared paper, 2021 · strength 0.13
  8. Jonathan M. DeLiberty · 1 shared paper, 2022 · strength 0.13
  9. Bjoern Papke · 1 shared paper, 2022 · strength 0.13
  10. Emanuel F. Petricoin · 1 shared paper, 2022 · strength 0.13
  11. A. Cole Edwards · 1 shared paper, 2022 · strength 0.13
  12. Mariaelena Pierobon · 1 shared paper, 2022 · strength 0.13
  13. Kirsten L. Bryant · 1 shared paper, 2022 · strength 0.13
  14. Adrienne D. Cox · 1 shared paper, 2022 · strength 0.13
  15. Clint A. Stalnecker · 1 shared paper, 2022 · strength 0.13
  16. Channing J. Der · 1 shared paper, 2022 · strength 0.13
  17. Craig M. Goodwin · 1 shared paper, 2022 · strength 0.13
  18. Susan M Fischer · 2 shared papers, 2011–2013 · strength 0.07
  19. Vincenza Cifarelli · 1 shared paper, 2015 · strength 0.05
  20. Michaël Pollak · 1 shared paper, 2015 · strength 0.05
  21. Rudolf Kaaks · 1 shared paper, 2015 · strength 0.05
  22. Craig D. Logsdon · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.